DR. HARISH V REDDY

Areas of Special Interest

– Medical management of solid tumors and
haematological malignancies.
– Chemotherapy, immunotherapy, and targeted
therapies.
– Personalized cancer care using molecular and
genetic profiling
– Tumor board-based multidisciplinary
treatment planning.
– Survivorship care and long-term follow-up care.
– Designing and conducting clinical trials.

Key Achievement

– Cancer forum lead, Isle of Wright, UK.
– Bladder Cancer lead, UK

Research & Publication

– Frequent early failure of Kivexa containing
regimes associated with new emergence of
K65R.
– Is it worth giving adjuvant chemotherapy to
patients with Oesophagogastric cancer who do
not show a histopathological response to
neoadjuvant chemotherapy? 3.O085 CD10
expression in carcinomas of the pancreas, bile
duct and ampulla, British Journal of Surgery,
Volume 109.

Presentations

– ESTRO 33 annual meeting Apr 2014 (Vienna)
e-poster.
– 6th European Congress on Head and Neck
Oncology April 2014, Liverpool- Poster.
– Oral presentation at 10th Annual Resistance
meeting, London (Sep 21st 2006).
– National Webinar on “Clinical trials: An update”
Sri Devraj Urs Medical College (Jun 14th 2024)
Regulatory requirements for Academic Clinical
trials.
– Speaker at Allied Health services conference
(AHSCON) Jan 18th 2025.
– Poster presentation at FICCI Heal Nov 2024
Mortality review

Membership

– Royal College of Radiologists – Fellow.
– European Society of Medical Oncology.
– Karnataka Medical Council.
– Consortium of Accredited Healthcare
Organizations (CAHO), India.